New diabetes may be early warning for pancreatic cancer – study aims to find hidden cases

NCT ID NCT03937453

Recruiting now Knowledge-focused Sponsor: Nuvance Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether people aged 50+ who are newly diagnosed with diabetes (or whose diabetes gets worse) might have early-stage pancreatic cancer. Researchers will use MRI scans and collect blood samples over time to find cancer or pre-cancerous changes. The goal is to develop a simple blood test for earlier detection. 800 participants are being recruited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus malignant pancreatic neoplasm neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS PANCREATIC CANCER PANCREATIC NEOPLASMS

Contacts and locations

Locations

Nuvance Health
RECRUITING

Norwalk, Connecticut, 06856, United States
Yale University
NOT_YET_RECRUITING

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.